Function of filaggrin and caspase-14 in formation and maintenance of the epithelial barrier

Dermatologica Sinica

Volumn 27, Issue 1, 2009, Pages 1-14

  Presland, Richard B ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Atopic eczema; Caspase 14; Epithelial barrier; Filaggrin; Ichthyosis Vulgaris; Profilaggrin; Terminal differentiation

Indexed keywords

AMINO ACID; ASPARTATE AMMONIA LYASE; CASPASE 14; FILAGGRIN; PROFILAGGRIN; PROTEIN PRECURSOR; PROTEINASE;

ATOPIC DERMATITIS; CELL DIFFERENTIATION; DISEASE SEVERITY; DRY SKIN; ECZEMA; GENE EXPRESSION; GENE MUTATION; GENETIC VARIABILITY; HUMAN; ICHTHYOSIS; KERATINIZATION; KERATINOCYTE; NONHUMAN; NULL ALLELE; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RADIATION PROTECTION; REVIEW; SKIN EPITHELIUM; SKIN FUNCTION; SKIN PROTECTION; STRATUM CORNEUM; ULTRAVIOLET RADIATION;

EID: 63049089028     PISSN: 10278117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (94)

1. Presland RB, Dale BA: Epithelial structural proteins of the skin and oral cavity: function in health and disease. Crit Rev Oral Biol Med 11: 383-408, 2000.
2. Demerjian M, Hachem JP, Tschachler E, et al.: Acute modulations in permeability barrier function regulate epidermal cornification: role of caspase-14 and the protease-activated receptor type 2. Am J Pathol 172: 86-97, 2008.
3. Presland RB, Rothnagel JA, Lawrence OT: Profilaggrin and the fused S100 family of calcium-binding proteins. In: Elias PM, Feingold KR, eds. Skin Barrier. New York: Taylor and Francis, 111-140, 2006.
4. Jackson B, Tilli CM, Hardman MJ, et al.: Late cornified envelope family in differentiating epithelia - response to calcium and ultraviolet irradiation. J Invest Dermatol 124: 1062-1070, 2005.
5. Potten CS: Cell replacement in epidermis (keratopoiesis) via discrete units of proliferation. Int Rev Cytol 69: 271-318, 1981.
6. Presland RB, Haydock PV, Fleckman P, et al.: Characterization of the human epidermal profilaggrin gene. Genomic organization and identification of an S-100-like calcium binding domain at the amino terminus. J Biol Chem 267: 23772-23781, 1992.
7. Markova NG, Marekov LN, Chipev CC, et al.: Profilaggrin is a major epidermal calcium-binding protein. Mol Cell Biol 13: 613-625, 1993.
8. Resing KA, Dale BA: Proteins of keratohyalin. In: Goldsmith LA, ed. Physiology, Biochemistry, and Molecular Biology of the Skin. New York: Oxford University Press, 148-167, 1991.
9. Resing KA, Dale BA, Walsh KA: Multiple copies of phosphorylated filaggrin in epidermal profilaggrin demonstrated by analysis of tryptic peptides. Biochemistry 24: 4167-4175, 1985.
10. Lonsdale-Eccles JD, Teller DC, Dale BA: Characterization of a phosphorylated form of the intermediate filament-aggregating protein filaggrin. Biochemistry 21: 5940-5948, 1982.
11. Harding CR, Scott IR: Histidine-rich proteins (filaggrins): structural and functional heterogeneity during epidermal differentiation. J Mol Biol 170: 651-673, 1983.
12. Presland RB, Kuechle MK, Lewis SP, et al.: Regulated expression of human filaggrin in keratinocytes results in cytoskeletal disruption, loss of cell-cell adhesion, and cell cycle arrest. Exp Cell Res 270: 199-213, 2001.
13. Dale BA, Resing KA, Presland RB: Keratohyalin granule proteins. In: Leigh IM, Lane E B, Watt FM, eds. The Keratinocyte Handbook. Cambridge, UK: Cambridge University Press, 323-350, 1994.
14. Haydock PV, Dale BA: Filaggrin, an intermediate filament-associated protein: structural and functional implications from the sequence of a cDNA from rat. DNA Cell Biol 9: 251-261, 1990.
15. Kam E, Resing KA, Lim SK, et al.: Identification of rat epidermal profilaggrin phosphatase as a member of the protein phosphatase 2A family. J Cell Sci 106 (Pt 1): 219-226, 1993.
16. Resing KA, al-Alawi N, Blomquist C, et al.: Independent regulation of two cytoplasmic processing stages of the intermediate filament-associated protein filaggrin and role of Ca2+ in the second stage. J Biol Chem 268: 25139-25145, 1993.
17. Yamazaki M, Ishidoh K, Suga Y, et al.: Cytoplasmic processing of human profilaggrin by active mu-calpain. Biochem Biophys Res Commun 235:652-656, 1997.
18. Resing KA, Thulin C, Whiting K, et al.: Characterization of profilaggrin endoproteinase 1. A regulated cytoplasmic endoproteinase of epidermis. J Biol Chem 270: 28193-28198, 1995.
19. Pearton DJ, Nirunsuksiri W, Rehemtulla A, et al.: Proprotein convertase expression and localization in epidermis: evidence for multiple roles and substrates. Exp Dermatol 10: 193-203, 2001.
20. List K, Szabo R, Wertz PW, et al.: Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1. J Cell Biol 163: 901-910, 2003.
21. Leyvraz C, Charles RP, Rubera I, et al.: The epidermal barrier function is dependent on the serine protease CAP1/Prss8. J Cell Biol 170: 487-496, 2005.
22. Hoste E, Denecker G, Van Damme P, et al.: Identification and characterization of filaggrin as a caspase-14 substrate. Society of Investigative Dermatology: Abstract #426, S71, 2007.
23. Denecker G, Hoste E, Gilbert B, et al.: Caspase-14 protects against epidermal UVB photodamage and water loss. Nat Cell Biol 9: 666-674, 2007.
24. Chavanas S, Bodemer C, Rochat A, et al.: Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 25: 141-142, 2000.
25. Descargues P, Deraison C, Bonnart C, et al.: Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat Genet 37: 56-65, 2005.
26. Hewett DR, Simons AL, Mangan NE, et al.: Lethal, neonatal ichthyosis with increased proteolytic processing of filaggrin in a mouse model of Netherton syndrome. Hum Mol Genet 14: 335-346, 2005.
27. List K, Szabo R, Molinolo A, et al.: Delineation of matriptase protein expression by enzymatic gene trapping suggests diverging roles in barrier function, hair formation, and squamous cell carcinogenesis. Am J Pathol 168: 1513-1525, 2006.
28. Brody I: An ultrastructural study on the role of the keratohyalin granules in the keratinization process. J Ultrastruct Res 3: 84-104, 1959.
29. Manabe M, Sanchez M, Sun TT, et al.: Interaction of filaggrin with keratin filaments during advanced stages of normal human epidermal differentiation and in ichthyosis vulgaris. Differentiation 48: 43-50, 1991.
30. Steinert PM, Marekov LN: The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J Biol Chem 270: 17702-17711, 1995.
31. Candi E, Tarcsa E, Digiovanna JJ, et al.: A highly conserved lysine residue on the head domain of type II keratins is essential for the attachment of keratin intermediate filaments to the cornified cell envelope through isopeptide crosslinking by transglutaminases. Proc Natl Acad Sci U S A 95: 2067-2072, 1998.
32. Harding CR, Scott, IR: Stratum corneum moisturizing factors. In: Leyden JJ, Rawlings AV, eds. Skin Moisturization. Weimar: Culinary and Hospitality Industry Publication Services, 61-80, 2002.
33. Rawlings AV, Marts PJ: Stratum corneum moisturization at the molecular level: an update in relation to the dry skin cycle. J Invest Dermatol 124: 1099-1110, 2005.
34. de fine Olivarius F, Wulf HC, Crosby J, et al.: The sunscreening effect of urocanic acid. Photodermatol Photoimmunol Photomed 12: 95-99, 1996.
35. Kammeyer A, Eggelte TA, Bos JD, et al.: Urocanic acid isomers are good hydroxyl radical scavengers: a comparative study with structural analogues and with uric acid. Biochim Biophys Acta 1428: 117-120, 1999.
36. Walterscheid JP, Nghiem DX, Kazimi N, et al.: Cis-urocanic acid, a sunlight-induced immunosuppressive factor, activates immune suppression via the 5-HT2A receptor. Proc Natl Acad Sci U S A 103: 17420-17425, 2006.
37. Kaneko K, Smetana-Just U, Matsui M, et al.: cis-Urocanic acid initiates gene transcription in primary human keratinocytes. J Immunol 181: 217-224, 2008.
38. Ishida-Yamamoto A, Senshu T, Eady RA, et al.: Sequential reorganization of cornified cell keratin filaments involving filaggrin-mediated compaction and keratin 1 deimination. J Invest Dermatol 118: 282-287, 2002.
39. Tarcsa E, Marekov LN, Mei G, et al.: Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin. J Biol Chem 271: 30709-30716, 1996.
40. Denecker G, Ovaere P, Vandenabeele P, et al.: Caspase-14 reveals its secrets. J Cell Biol 180: 451-458, 2008.
41. Caubet C, Jonca N, Brattsand M, et al.: Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J Invest Dermatol 122: 1235-1244, 2004.
42. Kawada A, Hara K, Morimoto K, et al.: Rat epidermal cathepsin B: purification and characterization of proteolytic properties toward filaggrin and synthetic substrates. Int J Biochem Cell Biol 27: 175-183, 1995.
43. Kawada A, Hara K, Hiruma M, et al.: Rat epidermal cathepsin L-like proteinase: purification and some hydrolytic properties toward filaggrin and synthetic substrates. J Biochem 118: 332-337, 1995.
44. Scott IR, Harding CR: Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment. Dev Biol 115: 84-92, 1986.
45. Simon M, Haftek M, Sebbag M, et al.: Evidence that filaggrin is a component of cornified cell envelopes in human plantar epidermis. Biochem J 317 (Pt 1): 173-177, 1996.
46. Pearton DJ, Dale BA, Presland RB: Functional analysis of the profilaggrin N-terminal peptide: identification of domains that regulate nuclear and cytoplasmic distribution. J Invest Dermatol 119: 661-669, 2002.
47. Presland RB, Kimball JR, Kautsky MB, et al.: Evidence for specific proteolytic cleavage of the N-terminal domain of human profilaggrin during epidermal differentiation. J Invest Dermatol 108: 170-178, 1997.
48. Ishida-Yamamoto A, Takahashi H, Presland RB, et al.: Translocation of profilaggrin N-terminal domain into keratinocyte nuclei with fragmented DNA in normal human skin and loricrin keratoderma. Lab Invest 78: 1245-1253, 1998.
49. Eckert RL, Broome AM, Ruse M, et al.: S100 proteins in the epidermis. J Invest Dermatol 123: 23-33, 2004.
50. MacLeod TJ, Kwon M, Filipenko NR, et al.: Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin. J Biol Chem 278: 25577-25584, 2003.
51. Passananti C, Fanciulli M: The anti-apoptotic factor Che-1/AATF links transcriptional regulation, cell cycle control, and DNA damage response. Cell Div 2: 21, 2007.
52. Wells RS, Kerr CB: Clinical features of autosomal dominant and sex-linked ichthyosis in an English population. Br Med J 1: 947-950, 1966.
53. Fleckman P, Brumbaugh S: Absence of the granular layer and keratohyalin defne a morphologically distinct subset of individuals with ichthyosis vulgaris. Exp Dermatol 11: 327-336, 2002.
54. Sybert VP, Dale BA, Holbrook KA: Ichthyosis vulgaris: identification of a defect in synthesis of filaggrin correlated with an absence of keratohyaline granules. J Invest Dermatol 84: 191-194, 1985.
55. Smith FJ, Irvine AD, Terron-Kwiatkowski A, et al.: Loss-of-function mutations in the gene encoding filaggrin cause iehthyosis vulgaris. Nat Genet 38: 337-342, 2006.
56. Sandilands A, Terron-Kwiatkowski A, Hull PR, et al.: Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 39: 650-654, 2007.
57. Sandilands A, Smith FJ, Irvine AD, et al.: Filaggrin's fuller figure: a glimpse into the genetic architecture of atopic dermatitis. J Invest Dermatol 127: 1282-1284, 2007.
58. O'Regan GM, Sandilands A, McLean WH, et al.: Filaggrin in atopic dermatitis. J Allergy Clin Immunol I22: 689-693, 2008.
59. Nomura T, Sandilands A, Akiyama M, et al.: Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis. J Allergy Clin Immunol 119: 434-440, 2007.
60. Chen H, Ho JC, Sandilands A, et al.: Unique and recurrent mutations in the filaggrin gene in Singaporean Chinese patients with ichthyosis vulgaris. J Invest Dermatol 128: 1669-1675, 2008.
61. Kezic S, Kemperman PM, Koster ES, et al.: Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum. J Invest Dermatol 128: 2117-2119, 2008.
62. Presland RB, Boggess D, Lewis SP, et al.: Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris. J Invest Dermatol 115: 1072-1081, 2000.
63. Morar N, Willis-Owen SA, Moffatt MF, et al.: The genetics of atopic dermatitis. J Allergy Clin Immunol 118: 24-34, 2006.
64. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al.: Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38: 441-446, 2006.
65. Irvine AD: Fleshing out filaggrin phenotypes. J Invest Dermatol 127:504-507, 2007.
66. Brown SJ, Sandilands A, Zhao Y, et al.: Prevalent and low-frequency null mutations in the filaggrin gene are associated with early-onset and persistent atopic eczema. J Invest Dermatol 128:1591-1594, 2008.
67. Nomura T, Akiyama M, Sandilands A, et al.: Specific filaggrin mutations cause ichthyosis vulgaris and are significantly associated with atopic dermatitis in Japan. J Invest Dermatol 128: 1436-1441, 2008.
68. Basu K, Palmer CN, Lipworth BJ, et al.: Filaggrin null mutations are associated with increased asthma exacerbations in children and young adults. Allergy 63: 1211-1217, 2008.
69. McLean WH, Palmer CN, Henderson J, et al.: Filaggrin variants confer susceptibility to asthma. J Allergy Clin Immunol 121: 1294-1295, 2008.
70. Weidinger S, O'Sullivan M, Illig T, et al.: Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol 121: 1203-1209 el, 2008.
71. Marenholz I, Nickel R, Ruschendorf F, et al.: Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol 118: 866-871, 2006.
72. Ying S, Meng Q, Corrigan CJ, et al.: Lack of filaggrin expression in the human bronchial mucosa. J Allergy Clin Immunol 118: 1386-1388, 2006.
73. Hudson TJ: Skin barrier function and allergic risk. Nat Genet 38: 399-400, 2006.
74. Howell MD, Kim BE, Gao P, et al.: Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 120: 150-155, 2007.
75. Spergel JM, Mizoguchi E, Brewer JP, et al.: Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 101: 1614-1622, 1998.
76. Elias PM, Hatano Y, Williams ML: Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol 121: 1337-1343, 2008.
77. Hathaway TR, Kuechle MK: Apoptosis and cutaneous biology. Adv Dermatol 18: 287-311, 2002.
78. Kam DW, Charles AK, Dharmarajan AM: Caspase-14 expression in the human placenta. Reprod Biomed Online 11: 236-243, 2005.
79. Kuechle MK, Predd HM, Fleekman P, et al.: Caspase-14, a keratinocyte specific caspase: mRNA splice variants and expression pattern in embryonic and adult mouse. Cell Death Differ 8: 868-870, 2001.
80. Fischer H, Rossiter H, Ghannadan M, et al.: Caspase-14 but not caspase-3 is processed during the development of fetal mouse epidermis. Differentiation 73: 406-413, 2005.
81. Lippens S, Kockx M, Knaapen M, et al.: Epidermal differentiation does not involve the proapoptotic executioner caspases, but is associated with caspase-14 induction and processing. Cell Death Differ 7: 1218-1224, 2000.
82. Chien AJ, Presland RB, Kuechle MK: Processing of native caspase-14 occurs at an atypical cleavage site in normal epidermal differentiation. Biochem Biophys Res Commun 296: 911-917, 2002.
83. Hu S, Snipas SJ, Vincenz C, et al.: Caspase-14 is a novel developmentally regulated protease. J Biol Chem 273: 29648-29653, 1998.
84. Mikolajczyk J, Scott FL, Krajewski S, et al.: Activation and substrate specificity of caspase-14. Biochemistry 43: 10560-10569, 2004.
85. Park K, Kuechle MK, Choe Y, et al.: Expression and characterization of constitutively active human caspase-14. Biochem Biophys Res Commun 347: 941-948, 2006.
86. Alibardi L, Dockal M, Reinisch C, et al.: Ultra-structural localization of caspase-14 in human epidermis. J Histochem Cytochem 52: 1561-1574, 2004.
87. Fischer H, Stichenwirth M, Dockal M, et al.: Stratum corneum-derived caspase-14 is catalytically active. FEBS Lett 577: 446-450, 2004.
88. Raymond AA, Mechin MC, Nachat R, et al.: Nine procaspases are expressed in normal human epidermis, but only caspase-14 is fully processed. Br J Dermatol 156: 420-427, 2007.
89. Liao H, Waters AJ, Goudie DR, et al.: Filaggrin mutations are genetic modifying factors exacerbating X-linked ichthyosis. J Invest Dermatol 127: 2795-2798, 2007.
90. Betz RC, Pforr J, Flaquer A, et al.: Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease. J Invest Dermatol 127: 2539-2543, 2007.
91. Ginger RS, Blachford S, Rowland J, et al.: Filaggrin repeat number polymorphism is associated with a dry skin phenotype. Arch Dermatol Res 297: 235-241, 2005.
92. Kwiatkowski DP: How malaria has affected the human genome and what human genetics can teach us about malaria. Am J Hum Genet 77: 171-192, 2005.
93. Hoste E, Denecker G, Van Damme P, et al.: Caspase-14 is a crucial protease in proper stratum corneum formation. International Investigative Dermatology: Abstract #631, S106, 2008.
94. Gan SQ, McBride OW, Idler WW, et al.: Organization, structure, and polymorphisms of the human profilaggrin gene. Biochemistry 29: 9432-9440, 1990.